National Cancer Institute Thai Cancer Anemia Survey

Completed

• Conditions: Anemia; Cancer
• Interventions: Other: Adult Cancer Patients

• Registration Number: NCT01030159
• Lead Sponsor: Janssen-Cilag Ltd.,Thailand

Brief Summary

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Detailed Description

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Study Timeline

• Study Start: 2006-06
• Primary Completion: 2008-05
• Study Completion: 2008-05
• Study First Submitted: 2009-12-10
• Study First Submitted QC: 2009-12-10
• Study First Posted: 2009-12-11
• Status Verified: 2014-04
• Last Update Submitted: 2014-04-08
• Last Update Posted: 2014-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients with cancer

Exclusion Criteria

• N/A

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
001	Adult Cancer Patients	-

Primary Outcome Measures

Name	Time	Method
Number of patients that have anemia during cancer therapy	6 months

Secondary Outcome Measures

Name	Time	Method
Characteristics of patients example treatment duration, type of chemotherapy used, grade of anemia	6 months